Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

EBioMedicine

Topics

Medicine

Immunology

Physiology

Internal Medicine

Endocrinology

Show all topics

DOI

10.1016/j.ebiom.2019.08.069

License

CC-BY

Other Formats

PDF